About the Authors
- Joseph W. Golden, Matthew Josleyn, Jay W. Hooper
- Department of Molecular Virology, Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America
- Eric M. Mucker
- Department of Viral Therapeutics, Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America
- Chien-Fu Hung, T. C. Wu
- Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, United States of America
- Peter T. Loudon
- Pfizer, Sandwich Laboratories, Sandwich, Kent, United Kingdom
The authors have read the journal's policy and have the following conflicts: JWH has orthopoxvirus DNA vaccine patent (US Patent Number 6,562,376; JWH and JWG have patent application on a orthopoxvirus DNA vaccine component (US Patent Application Number 12/217584). PTL is employed by Pfizer. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Conceived and designed the experiments: JWG CFH PTL TCW JWH. Performed the experiments: JWG MJ EMM JWH. Analyzed the data: JWG EMM JWH. Contributed reagents/materials/analysis tools: EMM PTL TCW JWH. Wrote the paper: JWG EMM JWH.